<DOC>
	<DOC>NCT01026584</DOC>
	<brief_summary>The aim of the study is to investigate the efficacy and safety of aripiprazole in patients with first episode psychosis.</brief_summary>
	<brief_title>Efficacy and Safety of Aripiprazole in First Episode Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Aged 1859 years and meet DSMIV diagnostic criteria for first episode of schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder NOS as assessed by using the Structured Clinical Interview for DSMIV, research version. Meeting DSMIV criteria for another axis I diagnosis, including substance abuse or dependence Needing another nonantipsychotic psychotropic medication at enrollment Having a serious or unstable medical illness. Pregnant or lactating women or women without adequate contraception will be also excluded.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>